The scale of the global hepatitis B drug market was around US$2.15 billion in 2015 and is forecast to grow slowly at a CAGR of just 0.4% to US$2.2 billion in 2023, according to the latest biotechnology report from the global market research firm TrendForce.
With download and active user numbers far exceeding other popular apps, Nintendo’s Pokémon GO has generated an enormous wave of enthusiasm for mobile gaming and augmented reality (AR) technology worldwide. According to the latest analysis from the global market research firm TrendForce, the revenue from Pokémon GO is forecast to top US$800 million in 2017. The game is set to become a significant contributor to the expansion of the global AR software market, which will reach US$30 billion in scale by 2020.
Aging population and rising costs of new drugs have increased healthcare expenses in countries across the globe and spurred governments to expand the use of generic drugs. Currently, there are factors constraining the development of generics. The U.S., for instance, is pushing the international adoption of patent linkage via the Trans-Pacific Partnership (TPP) and Bilateral Free Trade Agreements (BFTAs).
China will continue to bolster the development of a domestic robotics industry, according to a new robotics technology roadmap that was recently released by the Chinese government for the 13th Five-Year Plan period (2016~2020). China aims to have three to five internationally competitive domestic robotics companies by 2020.
Japan has enormous influence over the development of the global biotech industry. The country is the world’s third-largest pharmaceutical and biotech market after the U.S. and China. It is also ranked second globally in terms of R&D spending in pharmaceutical and biotech industry. One of the major trade exhibitions in Japan, Life Science World 2016, was held in Tokyo earlier this May.